大博医疗：关于向激励对象授予预留股票期权的公告

Group 1 - The core point of the article is that Dabo Medical announced the approval of a stock option plan for 89 incentive targets, granting a total of 620,400 stock options at an exercise price of 23.39 yuan per option [2] - The board and supervisory meetings are scheduled for September 17, 2025, to review and approve the stock option grant [2] - The authorization date for the stock options is also set for September 17, 2025 [2]